We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Figure 1

Figure 1. From: Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.

Pedigree of PALB2 c.2323C>T [p.Q775X] mutation carrier family F1469. An arrow indicates the proband and only known mutation carrier in family F1469. Abbreviations: bilateral breast cancer (Bi Br), cerebral hemorrhage (CH) esophageal cancer (Eso), lung cancer (Lu), melanoma (Mel), stomach cancer (Sto), and uterine cancer (Ut). Age at ascertainment and/or death (d.) are indicated if known along with ages at diagnosis of cancer.

Marc Tischkowitz, et al. BMC Med Genet. 2013;14:5-5.
2.
Figure 2

Figure 2. From: Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.

Mutation analysis of PALB2 c.2323C>T [p.Q775X] containing region. DNA sequencing chromatogram showing the region containing the c.2323C sequence of normal reference sample (Panel A) and corresponding interval from lymphocyte DNA of c.2323 T mutation carrier (Panel B) and ovarian cancer specimen DNA from the same patient (Panel C). The arrow indicates the position of the mutation in the sequence chromatogram.

Marc Tischkowitz, et al. BMC Med Genet. 2013;14:5-5.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk